Treatment of hypercholesterolemia in pregnancy: Risks versus benefits

Journal of Pharmacy Technology

Volumn 21, Issue 5, 2005, Pages

  Zaiken, Kathy ^a   Raval, Kalindi D ^b  

^a MASSACHUSETTS COLLEGE OF PHARMACY AND HEALTH SCIENCES   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; COLESEVELAM; COLESTIPOL; COLESTYRAMINE; DEXTRAN SULFATE; EZETIMIBE; FENOFIBRATE; FIBRIC ACID DERIVATIVE; FISH OIL; GEMFIBROZIL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NICOTINIC ACID; OXIDIZED LOW DENSITY LIPOPROTEIN; PHYTOSTEROL; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL; VITAMIN K GROUP;

APHERESIS; ARTICLE; ATHEROGENESIS; BIBLIOGRAPHIC DATABASE; CHOLESTASIS; CLINICAL TRIAL; DIET THERAPY; DRUG EFFICACY; DRUG SAFETY; EMBASE; HUMAN; HYPERCHOLESTEROLEMIA; INTERNATIONAL PHARMACEUTICAL ABSTRACTS; LIPID BLOOD LEVEL; MEDLINE; PREGNANCY; RISK BENEFIT ANALYSIS; RISK FACTOR; SUBDURAL HEMATOMA; VITAMIN K DEFICIENCY;

EID: 24144456565     PISSN: 87551225     EISSN: None     Source Type: Journal    
DOI: 10.1177/875512250502100504     Document Type: Article

References (16)

1. Kroon AA, Swinkels DW, Van Dongen PWJ, Stalenhoef AFH. Pregnancy in patients with homozygous familial hypercholesterolemia treated with long-term low-density lipoprotein apheresis. Metabolism 1994;43:1164-70.
2. Rouse DJ, St. John E. Normal labor, delivery, newborn care, and puerperium. In: Scott JR, Gibbs RS, Karlan BY, Haney AF, eds. Danforth's obstetrics and gynecology. 9th ed. Philadelphia: Lippincott Williams and Wilkins, 2003. http://ezproxy.mcphs.edu:2458/gw2/ovidweb.cgi (accessed 2004 Feb 8).
3. Palinski W, Napoli C. Pathophysiological events during pregnancy influence the development of atherosclerosis in humans. Trends Cardiovasc Med 1999;9:205-14.
4. Napoli C, D'Armiento FP, Mancini FP, Postiglione A, Witztum JL, Palumbo G, et al. Fatty streak formation occurs in human fetal aortas and is greatly enhanced by maternal hypercholesterolemia. Intimal accumulation of low density lipoprotein and its oxidation precede monocyte recruitment into early atherosclerotic lesions. J Clin Invest 1997;100:2680-90.
5. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002;106:3143-421.
6. Napoli C, Palinski W. Maternal hypercholesterolemia during pregnancy influences the later development of atherosclerosis: clinical and pathogenic implications. Eur Heart J 2001;22:4-9.
7. Briggs GG, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation. 6th ed. Philadelphia: Lippincott Williams and Wilkins, 2002.
8. Hosokawa A, Bar-Oz B, Ito S. Use of lipid-lowering agents (statins) during pregnancy. Can Fam Physician 2003;49:747-9.
9. Napoli C, Glass CK, Witztum JL, Deutsch R, D'Armiento FP, Palinski W. Influence of maternal hypercholesterolemia during pregnancy on progression of early atherosclerotic lesions in childhood: Fate of Early Lesions in Children (FELIC) study. Lancet 1999;354: 1234-41.
10. Manson JM, Freyssinges C, Ducrocq MB, Stephenson WP. Post-marketing surveillance of lovastatin and simvastatin exposure during pregnancy. Reprod Toxicol 1996;10:439-46.
11. Sadler LC, Lane M, North R. Severe fetal intracranial hemorrhage during treatment with cholestyramine for intrahepatic cholestasis of pregnancy. Br J Obstet Gynaecol 1995;102:169-70.
12. Package insert. Zetia (ezetimibe). Kenilworth, NJ: Merck/Schering-Plough Pharmaceuticals. March 2003. www.zetia.com/zetia/shared/documents/zetia_pi.pdf (accessed 2004 June 20).
13. Olsen SF, Secher NJ, Tabor A, Weber T, Walker JJ, Gludd C. Randomised clinical trials of fish oil supplementation in high risk pregnancies. Fish Oil Trials in Pregnancy (FOTIP) team. Br J Obstet Gynaecol 2000;107:382-95.
14. Napoli C, Witztum JL, Calara F, de Nigris F, Palinski W. Maternal hypercholesterolemia enhances atherogenesis in normocholesterolemic rabbits, which is inhibited by antioxidant or lipid-lowering intervention during pregnancy: an experimental model of atherogenic mechanisms in human fetuses. Circ Res 2000;87:946-52.
15. Mora C, Teruel JL, Navarro J. Low-density lipoprotein apheresis in homozygous familial hypercholesterolemia. Am J Cardiol 2001; 88:202-3.
16. McMurry MP, Connor WE, Goplerud CP. The effects of dietary cholesterol upon the hypercholesterolemia of pregnancy. Metabolism 1981;30:869-79.